The invention provides aporphine and oxoaporphine compounds that have
endothelial nitric oxide synthase (eNOS) maintaining or enhancing
activities and may be used to manufacture a medicaments for preventing or
treating ischemic diseases in human and mammal, and the ischemic diseases
may include ischemic cerebral apoplexy, ischemic cerebral thrombosis,
ischemic cerebral embolism, hypoxic ischemic encephlopathy, ischemic
cardiac disease or ischemic enteropathy etc.